Drug recall · September 6, 2023
Clindamycin Phosphate Topical Solution USP recall
Why: Defective Container: slow leakage under the cap
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60
- Lots / codes
Lot # 118920, exp. January 2024.
- Quantity
- 11,350 bottles
- Company
- Contract Pharmaceuticals Limited Canada, Mississauga, N/A
- Distribution
- Nationwide in the USA.
- Initiated
- August 23, 2023 · Voluntary: Firm initiated
- Classified
- August 29, 2023
- Reported
- September 6, 2023
- Ended
- August 6, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clindamycin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.